Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1841
| Despition | DDAH1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1806 | Human SCGN Protein (AC1806) | 2 µg | inquiry |
| ACPP-1294 | DCC Blocking Peptide (AC1294) | 250 µg | inquiry |
| ACPP-1767 | Human YIF1B Protein (AC1767) | 5 µg | inquiry |
| ACPP-1481 | Human RDH12 Protein (AC1481) | 2 µg | inquiry |
| ACPP-1582 | Human PEDF Protein, HEK (AC1582) | 2 µg | inquiry |
| ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
| ACPP-1496 | Human SPINT2 Protein (AC1496) | 2 µg | inquiry |
| ACPP-1640 | Human Human GDF11 Protein (AC1640) | 100 µg | inquiry |
| ACPP-1752 | Human ASPA Protein (AC1752) | 5 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.